← Back to Screener
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
Price$10.60
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-12.92%
Price vs S&P 500 (4W)-4.59%
VGM Score55.56
Market Capitalization$257.58M
P/E Ratio (Annual)43.36x
All Metrics
Book Value / Share (Quarterly)$6.96
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)-8.10%
EPS (TTM)$0.22
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$0.22
EPS (Annual)$0.14
ROI (Annual)2.55%
Cash / Share (Quarterly)$0.00
P/E Basic Excl Extra (TTM)38.70x
P/E Normalized (Annual)43.36x
ROA (Last FY)2.48%
EBITD / Share (TTM)$-0.06
Cash Flow / Share (Annual)$-0.02
P/B Ratio1.10x
P/B Ratio (Quarterly)1.50x
ROA (TTM)2.79%
EPS Growth QoQ (YoY)3.63%
EPS Incl Extra (Annual)$0.14
Current Ratio (Annual)0.03x
Quick Ratio (Quarterly)0.03x
3-Month Avg Trading Volume0.12M
P/E Incl Extra (TTM)38.70x
52-Week High$10.61
EPS Excl Extra (Annual)$0.14
26-Week Price Return3.01%
Quick Ratio (Annual)0.02x
13-Week Price Return1.53%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.03x
Enterprise Value$257.66M
Cash / Share (Annual)$0.00
3-Month Return Std Dev2.44%
ROE (Last FY)2.55%
EPS Basic Excl Extra (Annual)$0.14
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$0.22
ROI (TTM)2.88%
Revenue / Share (Annual)$0.00
P/E Ratio (TTM)38.70x
Year-to-Date Return2.27%
5-Day Price Return0.09%
EPS Normalized (Annual)$0.14
Month-to-Date Return0.76%
EBITD / Share (Annual)$-0.07
P/E Excl Extra (TTM)38.70x
EPS Basic Excl Extra (TTM)$0.22
P/B Ratio (Annual)1.49x
Book Value / Share (Annual)$6.90
Price vs S&P 500 (13W)-8.21%
Beta-0.01x
Revenue / Share (TTM)$0.00
ROE (TTM)2.88%
52-Week Low$10.12
gGradeC
mGradeC
vgmGradeC
Show chart for
Industry Peers — Blank Checks / SPACs(771)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
DMAADrugs Made In America Acquisition Corp. Ordinary Shares | — | C | C | $10.60 |
| KCAC.WSKensington Capital Acquisition Corp. VI Class 1 redeemable warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 | F | A | A | $0.52 |
| CAEPCantor Equity Partners III, Inc. Class A Ordinary Shares | — | — | F | $7.52 |
| WLACWillow Lane Acquisition Corp. Class A Ordinary Shares | — | B | A | $34.05 |
| AACIUArmada Acquisition Corp. III Units | — | A | A | $10.08 |
| BACQRInflection Point Acquisition Corp. IV Right | — | D | D | $0.00 |
| BACQUInflection Point Acquisition Corp. IV Unit | — | D | D | $0.00 |
| AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | D | $9.96 |
| DMIIDrugs Made In America Acquisition II Corp. Ordinary Shares | — | — | C | $10.06 |
| DMIIRDrugs Made In America Acquisition II Corp. Right | — | — | C | $0.07 |
| DMIIUDrugs Made In America Acquisition II Corp. Unit | — | — | C | $10.15 |
About
Drugs Made In America Acquisition Corp is a special purpose acquisition company formed to identify and acquire pharmaceutical manufacturing companies operating in the United States. The company has not yet completed a business combination.